Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0000950123-10-084598
Filing Date
2010-09-08
Accepted
2010-09-08 16:46:49
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w79759e8vk.htm 425 14793
2 EX-99.1 w79759exv99w1.htm EX-99.1 12657
3 GRAPHIC w79759w7975900.gif GRAPHIC 2780
4 GRAPHIC w79759w7975901.gif GRAPHIC 4231
5 GRAPHIC w79759w7975902.gif GRAPHIC 2883
  Complete submission text file 0000950123-10-084598.txt   43502
Mailing Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121 2068380500
Trubion Pharmaceuticals, Inc (Subject) CIK: 0001298521 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-33054 | Film No.: 101062683
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filed by) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations